Japan Medical Imaging Market Report Size Share Growth Drivers Trends Opportunities & Forecast 2025–2030

Japan medical imaging market, worth USD 1.8 Bn, grows due to rising chronic diseases, geriatric population, and innovations in AI-enabled imaging technologies for better diagnostics.

Region:Asia

Author(s):Geetanshi

Product Code:KRAA4264

Pages:85

Published On:January 2026

About the Report

Base Year 2025

Japan Medical Imaging Market Overview

  • The Japan Medical Imaging Market is valued at USD 1.8 billion, based on a five-year historical analysis of equipment and modality-based revenues reported for Japan. This growth is primarily driven by advancements in imaging technologies, increasing prevalence of chronic and lifestyle-related diseases, and a growing aging population that demands more diagnostic imaging services. The market is also supported by government and payer initiatives aimed at enhancing healthcare infrastructure, expanding cancer and cardiovascular screening programs, and promoting early disease detection through imaging.
  • Tokyo, Osaka, and Yokohama are the dominant cities in the Japan Medical Imaging Market due to their advanced healthcare facilities, high concentration of hospitals and diagnostic centers, and significant investments in medical technology. These cities are also located within the broader Kanto and Kansai regions that host leading academic medical centers and imaging vendors, which further strengthens their market position and facilitates access to cutting-edge imaging solutions, including AI-enabled CT, MRI, and PET-CT, for healthcare providers.
  • In 2023, the Japanese government implemented updated reimbursement and approval pathways that accelerate the clinical use of AI and advanced imaging technologies in hospitals to improve diagnostic accuracy and patient outcomes, building on earlier regulatory reforms under the Pharmaceuticals and Medical Devices Act overseen by the Ministry of Health, Labour and Welfare (MHLW). In particular, the Pharmaceuticals and Medical Devices Act (Act No. 145 of 1960, as amended by MHLW and the Pharmaceuticals and Medical Devices Agency) sets binding requirements for marketing authorization, quality, and safety of CT, MRI, X-ray, nuclear medicine, and related software, including AI-enabled imaging systems. This framework requires healthcare facilities and vendors to use approved digital imaging systems that comply with performance, post?marketing surveillance, and traceability standards, thereby supporting nationwide adoption of modern and AI-supported medical imaging.
Japan Medical Imaging Market Size

Japan Medical Imaging Market Segmentation

By Product / Modality:The market is segmented into various imaging modalities, each serving distinct diagnostic needs. The primary modalities include X-ray Imaging Systems, CT Scanners, MRI Systems, Ultrasound Imaging Systems, Nuclear Imaging Systems (SPECT, PET), Mammography Systems, and Others (Fluoroscopy, Hybrid Imaging, etc.). In the overall diagnostic imaging services mix in Japan, X?ray accounts for the largest share of modality revenues, with X?ray retaining around one?third of diagnostic imaging services market value, followed by CT and ultrasound. High-field MRI systems, however, remain a critical growth segment due to their non-invasive nature and superior imaging capabilities, particularly in oncology and neurology, and their increasing use in advanced neuro, musculoskeletal, and prostate imaging.

Japan Medical Imaging Market segmentation by Product / Modality.

By End-User:The end-user segmentation includes Hospitals, Diagnostic Imaging Centers, Clinics, Academic Institutes and Research Organizations, and Others. Hospitals dominate the market as they are the primary providers of medical imaging services, equipped with comprehensive modality portfolios and staffed by specialized radiologists and technologists. Large university and tertiary hospitals in major metropolitan areas lead early adoption of AI-assisted imaging protocols, hybrid PET?CT and PET?MRI systems, and advanced PACS/RIS integration, while independent diagnostic imaging centers are gradually increasing their share by offering high-throughput, cost-efficient scanning services.

Japan Medical Imaging Market segmentation by End-User.

Japan Medical Imaging Market Competitive Landscape

The Japan Medical Imaging Market is characterized by a dynamic mix of regional and international players. Leading participants such as Canon Medical Systems Corporation, Fujifilm Holdings Corporation, Hitachi, Ltd. (Hitachi Healthcare / Hitachi Medical), Siemens Healthineers Japan, GE Healthcare Japan Corporation, Philips Japan, Ltd. (Koninklijke Philips N.V.), Shimadzu Corporation, Hologic, Inc., Agfa-Gevaert Group, Carestream Health, Inc., Mindray Medical International Limited, Samsung Medison Co., Ltd., Koning Corporation, EIZO Corporation, Other Emerging Domestic Players contribute to innovation, geographic expansion, and service delivery in this space.

Canon Medical Systems Corporation

1948

Tochigi, Japan

Fujifilm Holdings Corporation

1934

Tokyo, Japan

Hitachi, Ltd. (Hitachi Healthcare)

1910

Tokyo, Japan

Siemens Healthineers Japan

1847

Tokyo, Japan

GE Healthcare Japan Corporation

1892

Tokyo, Japan

Company

Establishment Year

Headquarters

Global and Japan Market Share (%)

Japan Medical Imaging Revenue (USD Million)

3-Year Revenue CAGR in Japan (%)

Installed Base in Japan (Number of Systems)

Annual System Shipments to Japan (Units)

Average Selling Price (ASP) Trend in Japan

Japan Medical Imaging Market Industry Analysis

Growth Drivers

  • Increasing Prevalence of Chronic Diseases:The rise in chronic diseases such as diabetes and cardiovascular conditions is a significant growth driver for the medical imaging market in Japan. In future, approximately 10 million people are expected to be diagnosed with diabetes, leading to increased imaging needs for monitoring and diagnosis. The healthcare expenditure related to chronic diseases is projected to reach ¥40 trillion, emphasizing the demand for advanced imaging technologies to support early detection and management.
  • Technological Advancements in Imaging Modalities:Continuous innovations in imaging technologies, such as MRI and CT scans, are propelling market growth. In future, the Japanese market is expected to see a 15% increase in the adoption of AI-integrated imaging systems, enhancing diagnostic accuracy. The introduction of high-resolution imaging and 3D visualization techniques is projected to improve patient outcomes, with an estimated 20% reduction in diagnostic errors, further driving demand for these advanced modalities.
  • Rising Geriatric Population:Japan's aging population is a critical factor influencing the medical imaging market. In future, over 30% of the population will be aged 65 and older, leading to a higher incidence of age-related diseases requiring imaging services. The government’s healthcare budget for elderly care is expected to exceed ¥20 trillion, highlighting the need for efficient imaging solutions to cater to this demographic's healthcare requirements, thus driving market growth.

Market Challenges

  • High Cost of Advanced Imaging Equipment:The substantial investment required for advanced imaging equipment poses a significant challenge for healthcare providers in Japan. The average cost of MRI machines can exceed ¥100 million, making it difficult for smaller facilities to acquire such technology. This financial barrier limits access to cutting-edge imaging services, particularly in rural areas, where healthcare budgets are constrained, impacting overall market growth.
  • Shortage of Skilled Professionals:The medical imaging sector faces a critical shortage of trained professionals, which hampers service delivery. In future, it is estimated that Japan will need an additional 15,000 radiologists to meet the growing demand for imaging services. This shortage is exacerbated by an aging workforce, with nearly 40% of current radiologists expected to retire within the next decade, creating a significant gap in expertise and impacting patient care.

Japan Medical Imaging Market Future Outlook

The future of the medical imaging market in Japan appears promising, driven by technological advancements and demographic shifts. The integration of AI and machine learning into imaging technologies is expected to enhance diagnostic capabilities significantly. Additionally, the increasing focus on value-based healthcare will likely lead to more efficient imaging practices. As healthcare infrastructure continues to evolve, the demand for innovative imaging solutions will grow, ensuring that the market remains dynamic and responsive to patient needs.

Market Opportunities

  • Expansion of Telemedicine Services:The rise of telemedicine presents a unique opportunity for the medical imaging market. In future, telemedicine consultations are projected to increase by 25%, allowing for remote imaging interpretations. This shift can enhance access to imaging services, particularly in underserved areas, and improve patient engagement, ultimately driving market growth and innovation in imaging technologies.
  • Development of Portable Imaging Devices:The demand for portable imaging devices is on the rise, particularly in emergency and rural healthcare settings. In future, the market for portable ultrasound devices is expected to grow by 30%, driven by their ease of use and accessibility. This trend will facilitate timely diagnostics and improve patient outcomes, creating significant opportunities for manufacturers and healthcare providers alike.

Scope of the Report

SegmentSub-Segments
By Product / Modality

X-ray Imaging Systems

CT Scanners

MRI Systems

Ultrasound Imaging Systems

Nuclear Imaging Systems (SPECT, PET)

Mammography Systems

Others (Fluoroscopy, Hybrid Imaging, etc.)

By End-User

Hospitals

Diagnostic Imaging Centers

Clinics

Academic Institutes and Research Organizations

Others

By Application

Oncology

Cardiovascular and Thoracic

Neuro and Spine

Orthopedics and Musculoskeletal

Obstetrics and Gynecology

General Imaging

Breast Health

Others

By Technology

Digital Imaging

Analog / Conventional Imaging

Hybrid Imaging

AI-Enabled / Advanced Imaging Solutions

By Region

Kanto Region

Kansai / Kinki Region

Central / Chubu Region

Kyushu-Okinawa Region

Tohoku Region

Chugoku Region

Hokkaido Region

Shikoku Region

Key Target Audience

Investors and Venture Capitalist Firms

Government and Regulatory Bodies (e.g., Ministry of Health, Labour and Welfare; Pharmaceuticals and Medical Devices Agency)

Manufacturers and Producers

Distributors and Retailers

Healthcare Providers and Hospitals

Medical Imaging Equipment Suppliers

Industry Associations (e.g., Japan Medical Imaging and Radiological Systems Manufacturers Association)

Financial Institutions

Players Mentioned in the Report:

Canon Medical Systems Corporation

Fujifilm Holdings Corporation

Hitachi, Ltd. (Hitachi Healthcare / Hitachi Medical)

Siemens Healthineers Japan

GE Healthcare Japan Corporation

Philips Japan, Ltd. (Koninklijke Philips N.V.)

Shimadzu Corporation

Hologic, Inc.

Agfa-Gevaert Group

Carestream Health, Inc.

Mindray Medical International Limited

Samsung Medison Co., Ltd.

Koning Corporation

EIZO Corporation

Other Emerging Domestic Players

Table of Contents

Market Assessment Phase

1. Executive Summary and Approach


2. Japan Medical Imaging Market Overview

2.1 Key Insights and Strategic Recommendations

2.2 Japan Medical Imaging Market Overview

2.4 Evolution of Market Ecosystem

2.5 Timeline of Key Regulatory Milestones

2.6 Value Chain & Stakeholder Mapping

2.7 Business Cycle Analysis

2.8 Policy & Incentive Landscape


3. Japan Medical Imaging Market Analysis

3.1 Growth Drivers

3.1.1 Increasing prevalence of chronic diseases
3.1.2 Technological advancements in imaging modalities
3.1.3 Rising geriatric population
3.1.4 Growing demand for early diagnosis

3.2 Market Challenges

3.2.1 High cost of advanced imaging equipment
3.2.2 Stringent regulatory requirements
3.2.3 Shortage of skilled professionals
3.2.4 Competition from alternative diagnostic methods

3.3 Market Opportunities

3.3.1 Expansion of telemedicine services
3.3.2 Development of portable imaging devices
3.3.3 Increasing investment in healthcare infrastructure
3.3.4 Collaborations with technology firms

3.4 Market Trends

3.4.1 Integration of AI in imaging technologies
3.4.2 Shift towards value-based healthcare
3.4.3 Growth of outpatient imaging centers
3.4.4 Rising focus on patient-centric imaging solutions

3.5 Government Regulation

3.5.1 Medical Device Regulation Act
3.5.2 Health Insurance Act
3.5.3 Radiation Protection Regulations
3.5.4 Quality Assurance Standards for Imaging Devices

4. SWOT Analysis


5. Stakeholder Analysis


6. Porter's Five Forces Analysis


7. Japan Medical Imaging Market Market Size, 2019-2024

7.1 By Value

7.2 By Volume

7.3 By Average Selling Price


8. Japan Medical Imaging Market Segmentation

8.1 By Product / Modality

8.1.1 X-ray Imaging Systems
8.1.2 CT Scanners
8.1.3 MRI Systems
8.1.4 Ultrasound Imaging Systems
8.1.5 Nuclear Imaging Systems (SPECT, PET)
8.1.6 Mammography Systems
8.1.7 Others (Fluoroscopy, Hybrid Imaging, etc.)

8.2 By End-User

8.2.1 Hospitals
8.2.2 Diagnostic Imaging Centers
8.2.3 Clinics
8.2.4 Academic Institutes and Research Organizations
8.2.5 Others

8.3 By Application

8.3.1 Oncology
8.3.2 Cardiovascular and Thoracic
8.3.3 Neuro and Spine
8.3.4 Orthopedics and Musculoskeletal
8.3.5 Obstetrics and Gynecology
8.3.6 General Imaging
8.3.7 Breast Health
8.3.8 Others

8.4 By Technology

8.4.1 Digital Imaging
8.4.2 Analog / Conventional Imaging
8.4.3 Hybrid Imaging
8.4.4 AI-Enabled / Advanced Imaging Solutions

8.5 By Region

8.5.1 Kanto Region
8.5.2 Kansai / Kinki Region
8.5.3 Central / Chubu Region
8.5.4 Kyushu-Okinawa Region
8.5.5 Tohoku Region
8.5.6 Chugoku Region
8.5.7 Hokkaido Region
8.5.8 Shikoku Region

9. Japan Medical Imaging Market Competitive Analysis

9.1 Market Share of Key Players

9.2 Cross Comparison of Key Players

9.2.1 Company Name
9.2.2 Global and Japan Market Share (%)
9.2.3 Japan Medical Imaging Revenue (USD Million)
9.2.4 3-Year Revenue CAGR in Japan (%)
9.2.5 Installed Base in Japan (Number of Systems)
9.2.6 Annual System Shipments to Japan (Units)
9.2.7 Average Selling Price (ASP) Trend in Japan
9.2.8 R&D Intensity (% of Revenue)
9.2.9 New Product Launches in Last 3 Years (Japan)
9.2.10 Service & Maintenance Revenue Share (%)
9.2.11 Geographic Penetration Across Prefectures (Coverage)
9.2.12 Key Hospital / Provider Accounts in Japan
9.2.13 Regulatory & Reimbursement Approvals (Number of Approved Systems)

9.3 SWOT Analysis of Top Players

9.4 Pricing Analysis

9.5 Detailed Profile of Major Companies

9.5.1 Canon Medical Systems Corporation
9.5.2 Fujifilm Holdings Corporation
9.5.3 Hitachi, Ltd. (Hitachi Healthcare / Hitachi Medical)
9.5.4 Siemens Healthineers Japan
9.5.5 GE Healthcare Japan Corporation
9.5.6 Philips Japan, Ltd. (Koninklijke Philips N.V.)
9.5.7 Shimadzu Corporation
9.5.8 Hologic, Inc.
9.5.9 Agfa-Gevaert Group
9.5.10 Carestream Health, Inc.
9.5.11 Mindray Medical International Limited
9.5.12 Samsung Medison Co., Ltd.
9.5.13 Koning Corporation
9.5.14 EIZO Corporation
9.5.15 Other Emerging Domestic Players

10. Japan Medical Imaging Market End-User Analysis

10.1 Procurement Behavior of Key Ministries

10.1.1 Ministry of Health, Labour and Welfare
10.1.2 Ministry of Education, Culture, Sports, Science and Technology
10.1.3 Ministry of Economy, Trade and Industry
10.1.4 Others

10.2 Corporate Spend on Infrastructure & Energy

10.2.1 Healthcare Infrastructure Investments
10.2.2 Energy Efficiency Initiatives
10.2.3 Technology Upgrades
10.2.4 Others

10.3 Pain Point Analysis by End-User Category

10.3.1 Hospitals
10.3.2 Diagnostic Centers
10.3.3 Research Institutions
10.3.4 Others

10.4 User Readiness for Adoption

10.4.1 Training and Support Needs
10.4.2 Technology Familiarity
10.4.3 Budget Constraints
10.4.4 Others

10.5 Post-Deployment ROI and Use Case Expansion

10.5.1 ROI Measurement Techniques
10.5.2 Use Case Development
10.5.3 Long-term Value Assessment
10.5.4 Others

11. Japan Medical Imaging Market Future Size, 2025-2030

11.1 By Value

11.2 By Volume

11.3 By Average Selling Price


Go-To-Market Strategy Phase

1. Whitespace Analysis + Business Model Canvas

1.1 Market Gaps Identification

1.2 Business Model Development


2. Marketing and Positioning Recommendations

2.1 Branding Strategies

2.2 Product USPs


3. Distribution Plan

3.1 Urban Retail Strategies

3.2 Rural NGO Tie-ups


4. Channel & Pricing Gaps

4.1 Underserved Routes

4.2 Pricing Bands


5. Unmet Demand & Latent Needs

5.1 Category Gaps

5.2 Consumer Segments


6. Customer Relationship

6.1 Loyalty Programs

6.2 After-sales Service


7. Value Proposition

7.1 Sustainability Initiatives

7.2 Integrated Supply Chains


8. Key Activities

8.1 Regulatory Compliance

8.2 Branding

8.3 Distribution Setup


9. Entry Strategy Evaluation

9.1 Domestic Market Entry Strategy

9.1.1 Product Mix
9.1.2 Pricing Band
9.1.3 Packaging

9.2 Export Entry Strategy

9.2.1 Target Countries
9.2.2 Compliance Roadmap

10. Entry Mode Assessment

10.1 JV

10.2 Greenfield

10.3 M&A

10.4 Distributor Model


11. Capital and Timeline Estimation

11.1 Capital Requirements

11.2 Timelines


12. Control vs Risk Trade-Off

12.1 Ownership vs Partnerships


13. Profitability Outlook

13.1 Breakeven Analysis

13.2 Long-term Sustainability


14. Potential Partner List

14.1 Distributors

14.2 JVs

14.3 Acquisition Targets


15. Execution Roadmap

15.1 Phased Plan for Market Entry

15.1.1 Market Setup
15.1.2 Market Entry
15.1.3 Growth Acceleration
15.1.4 Scale & Stabilize

15.2 Key Activities and Milestones

15.2.1 Activity Planning
15.2.2 Milestone Tracking

Research Methodology

ApproachModellingSample

Phase 1: Approach1

Desk Research

  • Analysis of market reports from industry associations such as the Japan Medical Imaging Association
  • Review of government publications and healthcare expenditure reports from the Ministry of Health, Labour and Welfare
  • Examination of academic journals and publications focusing on advancements in medical imaging technologies

Primary Research

  • Interviews with radiologists and imaging technicians to gather insights on current practices and technology adoption
  • Surveys with hospital administrators regarding procurement processes and budget allocations for imaging equipment
  • Field interviews with medical device manufacturers to understand product development trends and market needs

Validation & Triangulation

  • Cross-validation of findings through multiple data sources including sales data and clinical usage statistics
  • Triangulation of insights from primary interviews with secondary data trends to ensure consistency
  • Sanity checks through expert panel reviews comprising industry veterans and academic professionals

Phase 2: Market Size Estimation1

Top-down Assessment

  • Estimation of the overall healthcare market size in Japan and its allocation to medical imaging
  • Segmentation of the market by imaging modalities such as MRI, CT, and ultrasound
  • Incorporation of demographic trends and aging population statistics influencing imaging demand

Bottom-up Modeling

  • Collection of sales data from leading medical imaging equipment manufacturers
  • Estimation of unit sales based on hospital and clinic procurement patterns
  • Analysis of pricing strategies and average selling prices for different imaging modalities

Forecasting & Scenario Analysis

  • Multi-factor regression analysis incorporating technological advancements and healthcare policy changes
  • Scenario modeling based on potential shifts in healthcare funding and insurance coverage
  • Baseline, optimistic, and pessimistic forecasts through 2030 based on market dynamics

Phase 3: CATI Sample Composition1

Scope Item/SegmentSample SizeTarget Respondent Profiles
Hospital Imaging Departments120Radiologists, Imaging Technologists
Private Imaging Clinics90Clinic Owners, Operations Managers
Medical Device Manufacturers70Product Managers, Sales Directors
Healthcare Policy Makers60Health Economists, Policy Analysts
Research Institutions60Clinical Researchers, Academic Professors

Frequently Asked Questions

What is the current value of the Japan Medical Imaging Market?

The Japan Medical Imaging Market is valued at approximately USD 1.8 billion. This valuation is based on a five-year historical analysis of equipment and modality-based revenues, reflecting the market's growth driven by technological advancements and increasing healthcare demands.

What factors are driving growth in the Japan Medical Imaging Market?

Which cities are the main hubs for the Japan Medical Imaging Market?

How is the Japanese government supporting the medical imaging sector?

Why Buy From Us?

Refine Robust Result (RRR) Framework
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follow Robust, Refine and Result (RRR) methodology. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents' facts and opinions, and Result for presenting data with story.

Our Reach Is Unmatched
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Shifting the Research Paradigm
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

More Insights-Better Decisions
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Transparency and Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

Round the Clock Support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Clients Choose Us?

400000+
Reports in repository
150+
Consulting projects a year
100+
Analysts
8000+
Client Queries in 2022